Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Hypothalamic insulin and glucagon-like peptide-1 levels in an animal model of depression and their effect on corticotropin-releasing hormone promoter gene activity in a hypothalamic cell line
It is generating extraordinary clinical interest because the Phase 3 trial data published on 21 May 2026 shows weight loss results that no licensed medication has achieved before
Overall prescribing rates (GLP-1 RA prescriptions as a proportion of all prescriptions) increased by more than one percentage point from December 2025 to March 2026 (+15.0%), representing the largest quarter-over-quarter percentage point increase observed since the start of the study period in 2019
An oral electrolyte replacement can be used but if loperamide is used the patient will have to be referred back to the prescribing doctor for dose adjustment because the risk of constipation which is a more serious problem
Limiting caffeine and alcohol during the first month further protects your stomach lining and reduces irritation
By activating GLP-1 receptors in the brain, semaglutide sends signals that promote feelings of fullness and reduce the desire to overeat
